Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Seizure Therapy for Schizophrenia - Trial

NCT06672588 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT06672588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06672588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Seizure Therapy for Schizophrenia - Trial
Lead sponsor
Centre for Addiction and Mental Health
Phase
Not applicable
Overall status
Recruiting
Start date
April 22, 2025
Completion date
November 30, 2028
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia, treatment resistant schizophrenia